Immune system modulatory pathways

The term **immune system modulatory pathways** refers broadly to families of cellular and molecular processes that govern the activation, suppression, and fine-tuning of immune responses[1][2][3][4][5][6][7]. These include pathways mediated by pattern recognition receptors (such as Toll-like receptors), cytokine signaling cascades, checkpoints (e.g., PD1-PDL1, CD40-CD40L), T cell activation, and antigen presentation routes. Therapies targeting these pathways can either enhance (immunostimulants) or suppress (immunosuppressants) immune activity and are central to modern treatments for cancer, autoimmune diseases, and transplantation. Because this nomenclature refers to a group of pathways—not a specific target or molecule—it cannot be mapped to a single receptor or protein. If a specific molecule is meant (e.g., "PD-1" or "Toll-like receptor 4"), please clarify for structured target data[1][2][3][4][5][6][7].

Other names

Immune modulatory pathwaysImmunomodulatory pathwaysImmunomodulation pathways

Suppression of immune cell activation; Enhancement of immune cell cytotoxicity; Blockade of immune checkpoints; Modulation of cytokine signaling; Reduction of inflammatory mediators; Promotion of immune tolerance.